Abstract:To reduce the side effects and enhance the anti-tumor activities of anticancer drugs in the clinic, the use of nano mesoporous materials, with mesoporous silica (MSN) being the best-studied, has become an effective method of drug delivery. In this study, we successfully synthesized mesoporous selenium (MSe) nanoparticles and first introduced them to the field of drug delivery. Loading MSe with doxorubicin (DOX) is mainly driven by the physical adsorption mechanism of the mesopores, and our results demonstrated that MSe could synergistically enhance the antitumor activity of DOX. Coating the surface of MSe@DOX with Human serum albumin (HSA) generated a unique redox-responsive nanoparticle (HSA-MSe@DOX) that demonstrated glutathione-dependent drug release, increased tumor-targeting effects and enhanced cellular uptake throug nanoparticle interact with SPARC in MCF-7 cells. In vitro, HSA-MSe@DOX prominently induced cancer cell toxicity by synergistically enhancing the effects of MSe and DOX. Moreover, HSA-MSe@DOX possessed tumor-targeting abilities in tumor-bearing nude mice and not only decreased the side effects associated with DOX, but also enhanced its antitumor activity. Therefore, HSA-MSe@DOX is a promising new drug that warrants further evaluation in the treatments of tumors.Statement of significanceTo reduce the side effects and enhance the anti-tumor activities of anticancer drugs, we successfully synthesized mesoporous selenium (MSe) nanoparticles and first introduced them to the field of drug delivery. Loading MSe with doxorubicin (DOX) is mainly driven by the physical adsorption mechanism of the mesopores. Coating the surface of MSe@DOX with Human serum albumin (HSA) generated a unique redox-responsive nanoparticle (HSA-MSe@DOX) that demonstrated glutathione-dependent drug release, increased tumor-targeting effects and enhanced cellular uptake throug nanoparticle interact with SPARC in MCF-7 cells. In vitro and in vivo, HSA-MSe@DOX possessed tumor-targeting abilities and not only decreased the side effects associated with DOX, but also enhanced its antitumor activity. Therefore, HSA-MSe@DOX is a promising new drug that warrants further evaluation in the treatments of tumors. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Selenium Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis Through Modulation of Phospho-Akt and Its Downstream Substrates

Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase

Doxorubicin and Selenium Cooperatively Induce Fas Signaling in the Absence of Fas/Fas Ligand Interaction.

Strategy to Enhance the Therapeutic Effect of Doxorubicin in Human Hepatocellular Carcinoma by Selenocystine, A Synergistic Agent That Regulates the Ros-Mediated Signaling

Selenocystine Potentiates Cancer Cell Apoptosis Induced by 5-Fluorouracil by Triggering Reactive Oxygen Species-Mediated DNA Damage and Inactivation of the ERK Pathway

Sodium Selenite Induces Apoptosis Via ROS‐mediated NF‐κB Signaling and Activation of the Bax–caspase‐9–caspase‐3 Axis in 4T1 Cells

Fish Oil and Selenium with Doxorubicin Modulates Expression of Fatty Acid Receptors and Selenoproteins, and Targets Multiple Anti-Cancer Signaling in Triple-negative Breast Cancer Tumors

Sensitization of Multidrug Resistant Cancer Cells to Doxorubicin Using Ebselen by Disturbing Cellular Redox Status

Selenocystine Induces Caspase-Independent Apoptosis in MCF-7 Human Breast Carcinoma Cells with Involvement of P53 Phosphorylation and Reactive Oxygen Species Generation.

Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in prostate cancer cells through enhancing caspase activation

Redox-responsive Mesoporous Selenium Delivery of Doxorubicin Targets MCF-7 Cells and Synergistically Enhances Its Anti-Tumor Activity.

Identification of Molecular Targets Associated with Selenium-Induced Growth Inhibition in Human Breast Cells Using Cdna Microarrays.

Methylseleninic Acid Potentiates Multiple Types Of Cancer Cells To Abt-737-Induced Apoptosis Involving Mcl-1, Akt-Bad, And Mitochondrial Cascade

Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad

Methylseleninic Acid Potentiates Apoptosis Induced By Chemotherapeutic Drugs In Androgen-Independent Prostate Cancer Cells

Synergistic Induction of Apoptosis by Methylseleninic Acid and Cisplatin, the Role of ROS-ERK/AKT-p53 Pathway

Caspase- and P53-Dependent Apoptosis in Breast Carcinoma Cells Induced by a Synthetic Selenadiazole Derivative

Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer.

Endoplasmic Reticulum Stress Signal Mediators Are Targets of Selenium Action

Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo